Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Avadel Pharmaceuticals PLC (AD - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
AVDL
Nasdaq
2834
https://www.avadel.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Avadel Pharmaceuticals PLC (AD
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q4 2023 Earnings Call Transcript
- Mar 5th, 2024 3:25 pm
Avadel Pharmaceuticals to Present at Upcoming Investor Conferences
- Mar 5th, 2024 1:00 pm
Avadel Pharmaceuticals Issues Statement On Patent Litigation
- Mar 4th, 2024 8:37 pm
Avadel Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
- Mar 4th, 2024 11:30 am
With 62% ownership, Avadel Pharmaceuticals plc (NASDAQ:AVDL) boasts of strong institutional backing
- Mar 1st, 2024 1:56 pm
Avadel Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full Year 2023 Financial Results on March 4
- Feb 26th, 2024 1:00 pm
Avadel Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
- Feb 7th, 2024 1:00 pm
Here's Why You Should Invest in Avadel (AVDL) Stock Now
- Jan 18th, 2024 3:35 pm
Shareholders have faith in loss-making Avadel Pharmaceuticals (NASDAQ:AVDL) as stock climbs 5.0% in past week, taking five-year gain to 516%
- Jan 18th, 2024 1:05 pm
Avadel (AVDL) is a Great Momentum Stock: Should You Buy?
- Jan 15th, 2024 5:00 pm
How Much Upside is Left in Avadel (AVDL)? Wall Street Analysts Think 37.36%
- Jan 15th, 2024 2:55 pm
Why Avadel Pharmaceuticals (AVDL) Stock Might be a Great Pick
- Jan 12th, 2024 1:32 pm
Avadel Pharmaceuticals Announces Strong LUMRYZ Launch Performance and Provides Preliminary Fourth Quarter and Full Year 2023 Financial Highlights
- Jan 8th, 2024 12:00 pm
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q3 2023 Earnings Call Transcript
- Nov 10th, 2023 5:16 pm
Avadel Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2023 Financial Results
- Nov 8th, 2023 12:00 pm
Avadel Pharmaceuticals to Provide a Corporate Update and Report Third Quarter Financial Results on November 8
- Oct 30th, 2023 12:00 pm
Avadel Pharmaceuticals Announces Data Supporting Clinical Profile for LUMRYZ™ (sodium oxybate) for extended-release oral suspension (CIII) at World Sleep 2023
- Oct 20th, 2023 12:00 pm
Avadel Pharmaceuticals to Present at the Jefferies Biotech CNS/Neuro Summit
- Oct 5th, 2023 12:00 pm
Avadel Pharmaceuticals PLC (AVDL): Is It Really Priced Right? An In-depth Exploration
- Sep 26th, 2023 3:52 pm
Avadel Pharmaceuticals plc's (NASDAQ:AVDL) institutional investors lost 7.6% last week but have benefitted from longer-term gains
- Sep 23rd, 2023 1:06 pm
Scroll